New cancer drug combo trial seeks to control advanced tumors

NCT ID NCT07035249

Summary

This study is testing whether adding an experimental drug called DCSZ11 to standard cancer treatments is safe and effective for people with advanced solid tumors that have spread. Researchers will enroll 9 adult patients with specific types of cancer to see how well the combination works. The main goal is to measure how many patients' tumors shrink or stop growing with this approach.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sichuan University West China Hospital, Chengdu, Sichuan

    RECRUITING

    Chengdu, Sichuan, 610041, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.